Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19

BACKGROUND: Severe cases of coronavirus disease 2019 (COVID-19) are characterized by progressive respiratory failure and the development of acute respiratory distress syndrome (ARDS), with high mortality rates for patients requiring mechanical ventilation. Levels of the vascular growth factor Angiop...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Rosie S., Smith, Patricia S., Berg, Paul H., de la Peña, Amparo, Cook, Paul P., Shawa, Imad, Kioussopoulos, Kathleen M., Hu, Yu, Schott, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382233/
https://www.ncbi.nlm.nih.gov/pubmed/35991210
http://dx.doi.org/10.1177/11795484221119316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382233/
https://www.ncbi.nlm.nih.gov/pubmed/35991210
http://dx.doi.org/10.1177/11795484221119316

Ejemplares similares